CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL

Show other versions (1)

Bibliographic Details
Main Authors:	P. A. Fedotov, M. Yu. Sitnikova, N. V. Safyanova, N. L. Shaporova
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	chronic heart failure chronic obstructive pulmonary disease β-adrenoblocker therapy nebivolol
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/9

Similar Items

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

NEBIVOLOL SAFETY AS CARDIOSELECTIVE Β-BLOCKER IN COMPLEX THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY CHRONIC OBSTRUCTIVE BRONCHITIS
by: Zh. G. Simonova, et al.
Published: (2003-10-01)

THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01)

Modern possibilities of correction of broncho-obstructive syndrome in chronic heart failure of ischemic origin in combination with chronic obstructive pulmonary disease: simple randomized parallel group study
by: Vladimir V. Evdokimov, et al.
Published: (2023-06-01)

NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. L. Dzhanaeva, et al.
Published: (2012-02-01)

CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA
by: S. Yu. Martsevich, et al.
Published: (2017-09-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

CARDIO-SELECTIVE BETA-ADRENOBLOCKER SAFETY IN CARDIOVASCULAR DISEASE TREATMENT AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: B. V. Trapeznikova, et al.
Published: (2010-06-01)

Nebivolol induced hyperkalemia: case report
by: Karmela Altabas, et al.
Published: (2016-01-01)

Influence of bisoprolol and nebivolol on the regulatory-adaptive status of patients with diastolic chronic heart failure
by: Pavel V. Khilkevich, et al.
Published: (2022-12-01)

EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
by: N. A. Koryagina, et al.
Published: (2014-12-01)

NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
by: Ni Putu Wirantari, et al.
Published: (2013-07-01)

Status and function of betaDadrenoreceptors and their modification during betaDblocker treatment in patients with arterial hypertension and chronic heart failure
by: O. A. Maneshina, et al.
Published: (2005-10-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

The Effect of Nebivolol on Subarachnoid Hemorrhage-induced Vasospasm in the Rabbit
by: İlker Güleç, et al.
Published: (2019-06-01)

Effects of nebivolol on artery hypertension--multicentre study Bosnia and Herzegovina
by: Zumreta Kušljugić, et al.
Published: (2005-02-01)

Chronic obstructive pulmonary diseases in children
by: Jose Dirceu Ribeiro, et al.
Published: (2015-11-01)

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS
by: E. I. Bambysheva, et al.
Published: (2016-05-01)

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015-09-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Nebivolol prevents the increase of asymmetric dimethylarginine and oxidants in hyperhomocysteinemic rats
by: Mustafa Ahmet Huyut
Published: (2019-01-01)

Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction
by: Kyungil Park, et al.
Published: (2023-09-01)

METHOD FOR THE PREDICTION OF THE DEVELOPMENT OF CHRONIC PULMONARY HEART IN COAL WORKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. Yu. Korotenko, et al.
Published: (2013-05-01)

Nebivolol And Quinapril Reduce P-Wave Duration And Dispersion In Hypertensive Patients
by: Hasan Korkmaz, et al.
Published: (2009-05-01)

ANTIBACTERIAL THERAPY OF EXACERBATIONS OF CHRONIC BRONCHITIS/CHRONIC OBSTRUCTIVE PULMONARY DISEASE: KEY PROVISIONS
by: A. I. Sinopalnikov, et al.
Published: (2017-11-01)

Is it possible to reverse frailty in patients with chronic obstructive pulmonary disease?
by: Zhe Wang, et al.
Published: (2020-10-01)

Lichenoid type cutaneous hyperpigmentation induced by nebivolol
by: Abdullah Nabi Aslan, et al.
Published: (2017-04-01)

Psychometric analysis of clinical chronic obstructive pulmonary disease questionnaire and chronic obstructive pulmonary disease assessment test and its correlation with St. George respiratory questionnaire in chronic obstructive pulmonary disease patients
by: Syed Aamir Ali, et al.
Published: (2022-01-01)

Modulation of TNF‐α, interleukin‐6, and interleukin‐10 by nebivolol–valsartan and nebivolol–lisinopril polytherapy in SHR rats
by: Lezama‐Martinez Diego, et al.
Published: (2024-04-01)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
by: Yong Bum Park, et al.
Published: (2023-07-01)

The importance of the relationship between chronic periodontitis and chronic obstructive pulmonary disease
by: Tamás Tián, et al.
Published: (2021-03-01)

Association of hypogonadism with the severity of chronic obstructive pulmonary disease
by: MA. Zohal, et al.
Published: (2015-12-01)

Management of chronic obstructive pulmonary disease: the Swiss Guidelines
by: E Grebski, et al.
Published: (2002-02-01)

Genetic risk factors of chronic obstructive pulmonary disease
by: PD Paré, et al.
Published: (2002-01-01)

EFFECTS OF NEBIVOLOL VS NADOLOL ON GLUCOSE AND LIPID METABOLISM IN OVERWEIGHT HYPERTENSIVE PATIENTS. A OPEN RANDOMIZED CONTROLLED STUDY
by: E. R. Berngardt, et al.
Published: (2003-06-01)

Activity of Plasma Proteolysis Indicators and Their Correction in Patients with Chronic Obstructive Pulmonary Disease Associated with Chronic Pancreatitis
by: T.M. Khrystych, et al.
Published: (2013-02-01)

New possibilities of pharmacotherapy for chronic obstructive pulmonary disease
by: A. I. Sinopalnikov, et al.
Published: (2018-10-01)

The Effect of Nebivolol on Acute Renal Injury Developed After Myocardial Ischemia: A Preclinical Study
by: Güldem Mercanoğlu, et al.
Published: (2018-09-01)